ADAPTIVE BIOTECHNOLOGIES CORPORATION Increase (Decrease) in Inventories
ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) reported Increase (Decrease) in Inventories of $754.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-04
- ADAPTIVE BIOTECHNOLOGIES CORPORATION increase (decrease) in inventories for the quarter ending 2026-06-30 was -$561.00K.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION increase (decrease) in inventories for the quarter ending 2026-03-31 was $1.31M.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION increase (decrease) in inventories for the quarter ending 2025-12-31 was $10.00K.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION increase (decrease) in inventories for the quarter ending 2025-09-30 was $1.35M.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION increase (decrease) in inventories for fiscal 2025 was $998.00K.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION increase (decrease) in inventories for fiscal 2024 was -$5.37M, a 289.29% decline from fiscal 2023.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION increase (decrease) in inventories for fiscal 2023 was $2.84M.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION increase (decrease) in inventories for fiscal 2022 was -$817.00K, a 115.71% decline from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$561.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $754.00K 10-Q · filed 2026-08-04 | $764.00K derived: sum of 3 quarters · filed 2026-08-04 | $2.11M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $1.31M 10-Q · filed 2026-05-05 | $1.32M derived: sum of 2 quarters · filed 2026-05-05 | $2.67M derived: sum of 3 quarters · filed 2026-05-05 | $2.58M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.36M derived: sum of 2 quarters · filed 2026-02-26 | $1.26M derived: sum of 3 quarters · filed 2026-08-04 | $998.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | $1.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $1.25M derived: sum of 2 quarters · filed 2026-08-04 | $988.00K 10-Q · filed 2025-11-05 | -$2.39M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | -$95.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$359.00K 10-Q · filed 2026-08-04 | -$3.74M derived: sum of 3 quarters · filed 2026-08-04 | -$5.44M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | -$264.00K 10-Q · filed 2026-05-05 | -$3.65M derived: sum of 2 quarters · filed 2026-05-05 | -$5.34M derived: sum of 3 quarters · filed 2026-05-05 | -$4.53M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$3.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$5.08M derived: sum of 2 quarters · filed 2026-02-26 | -$4.26M derived: sum of 3 quarters · filed 2026-02-26 | -$5.37M 10-K · filed 2026-02-26 |
| 2024-09-30 | -$1.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$879.00K derived: sum of 2 quarters · filed 2025-11-05 | -$1.99M 10-Q · filed 2025-11-05 | -$5.97M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $818.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$293.00K 10-Q · filed 2025-08-05 | -$4.27M derived: sum of 3 quarters · filed 2026-02-26 | -$4.00M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$1.11M 10-Q · filed 2025-05-01 | -$5.09M derived: sum of 2 quarters · filed 2026-02-26 | -$4.82M derived: sum of 3 quarters · filed 2026-02-26 | -$4.88M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$3.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$3.70M derived: sum of 2 quarters · filed 2026-02-26 | -$3.77M derived: sum of 3 quarters · filed 2026-02-26 | $2.84M 10-K · filed 2026-02-26 |
| 2023-09-30 | $273.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $208.00K derived: sum of 2 quarters · filed 2024-11-07 | $6.82M 10-Q · filed 2024-11-07 | $3.79M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | -$65.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $6.54M 10-Q · filed 2024-08-01 | $3.51M derived: sum of 3 quarters · filed 2025-03-03 | $3.44M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $6.61M 10-Q · filed 2024-05-07 | $3.58M derived: sum of 2 quarters · filed 2025-03-03 | $3.51M derived: sum of 3 quarters · filed 2025-03-03 | $4.05M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | -$3.03M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$3.10M derived: sum of 2 quarters · filed 2025-03-03 | -$2.56M derived: sum of 3 quarters · filed 2025-03-03 | -$817.00K 10-K · filed 2025-03-03 |
| 2022-09-30 | -$72.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $473.00K derived: sum of 2 quarters · filed 2023-11-09 | $2.21M 10-Q · filed 2023-11-09 | $3.24M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $545.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $2.28M 10-Q · filed 2023-08-02 | $3.32M derived: sum of 3 quarters · filed 2024-02-29 | $2.94M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $1.74M 10-Q · filed 2023-05-03 | $2.77M derived: sum of 2 quarters · filed 2024-02-29 | $2.39M derived: sum of 3 quarters · filed 2024-02-29 | $3.58M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $651.00K derived: sum of 2 quarters · filed 2024-02-29 | $1.84M derived: sum of 3 quarters · filed 2024-02-29 | $5.20M 10-K · filed 2024-02-29 |
| 2021-09-30 | -$381.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $809.00K derived: sum of 2 quarters · filed 2022-11-03 | $4.17M 10-Q · filed 2022-11-03 | $7.50M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | $1.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $4.55M 10-Q · filed 2022-08-03 | $7.88M derived: sum of 3 quarters · filed 2023-02-14 | $8.08M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-03-31 | $3.36M 10-Q · filed 2022-05-04 | $6.69M derived: sum of 2 quarters · filed 2023-02-14 | $6.89M derived: sum of 3 quarters · filed 2023-02-14 | $6.90M derived: sum of 4 quarters · filed 2023-02-14 |
| 2020-12-31 | $3.33M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $3.53M derived: sum of 2 quarters · filed 2023-02-14 | $3.54M derived: sum of 3 quarters · filed 2023-02-14 | $4.99M 10-K · filed 2023-02-14 |
| 2020-09-30 | $200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $218.00K derived: sum of 2 quarters · filed 2021-11-03 | $1.67M 10-Q · filed 2021-11-03 | $2.07M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | $18.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $1.47M 10-Q · filed 2021-08-04 | $1.87M derived: sum of 3 quarters · filed 2022-02-15 | $2.53M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | $1.45M 10-Q · filed 2021-05-05 | $1.85M derived: sum of 2 quarters · filed 2022-02-15 | $2.51M derived: sum of 3 quarters · filed 2022-02-15 | $2.66M derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | $402.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $1.06M derived: sum of 2 quarters · filed 2022-02-15 | $1.21M derived: sum of 3 quarters · filed 2022-02-15 | $1.23M 10-K · filed 2022-02-15 |
| 2019-09-30 | $663.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $812.00K derived: sum of 2 quarters · filed 2020-11-10 | $829.00K 10-Q · filed 2020-11-10 | $1.56M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $149.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $166.00K 10-Q · filed 2020-08-10 | $899.00K derived: sum of 3 quarters · filed 2021-02-24 | $291.00K derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $17.00K 10-Q · filed 2020-05-12 | $750.00K derived: sum of 2 quarters · filed 2021-02-24 | $142.00K derived: sum of 3 quarters · filed 2021-02-24 | |
| 2018-12-31 | $733.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $125.00K derived: sum of 2 quarters · filed 2021-02-24 | $3.05M 10-K · filed 2021-02-24 | |
| 2018-09-30 | -$608.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $2.31M 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | $2.92M 10-Q · filed 2019-08-13 | |||
| 2017-12-31 | $2.70M 10-K · filed 2020-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |